Value Drug Company v. Astrazeneca PLC

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Joel A. Pisano · 3,177 cases in index

Docket number

3:12-cv-05525

Nature of suit

410 Antitrust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts.

Jurisdiction

Federal question

Date filed

09/04/2012

Date terminated

12/10/2012

1,189 Antitrust cases in this court are indexed here.

Parties

• plaintiff · Value Drug Company · 20 cases
• defendant · Astrazeneca LP Pharmaceuticals & Biotechnology · 10349 cases

Part of a Larger Litigation Pattern

This is one of 10,350 Antitrust cases in our index naming ASTRAZENECA LP — a possible mass-tort or coordinated-litigation cluster.

• Giant Eagle, Inc v. Astrazeneca LP
  District Court, D. MassachusettsFiled 05/30/2013
• Giant Eagle, Inc v. Astrazeneca LP
  District Court, W.D. PennsylvaniaFiled 05/08/2013
• Laborers International Union of North America Local 17 Health Care Fund v. Astrazeneca LP
  District Court, D. MassachusettsFiled 12/20/2012
• Fraternal Order of Police Miami Lodge 20, Insurance Trust Fund v. Astrazeneca LP
  District Court, D. MassachusettsFiled 12/11/2012
• Value Drug Company v. AstraZeneca PLC
  District Court, D. MassachusettsFiled 12/10/2012
• Fraternal Order of Police Miam v. Astrazeneca LP, Et Al
  District Court, E.D. PennsylvaniaFiled 12/07/2012

About Antitrust Lawsuits

Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

Frequently Asked Questions

What is Value Drug Company v. Astrazeneca PLC?

Value Drug Company v. Astrazeneca PLC is a federal antitrust lawsuit filed on 09/04/2012 in the District Court, D. New Jersey. The case was terminated on 12/10/2012. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What type of case is this?

It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 3:12-cv-05525.

When was the case filed?

Value Drug Company v. Astrazeneca PLC was filed on 09/04/2012. It was terminated on 12/10/2012.